The Global Health Body Issues Alert Over Critical Shortage of Obesity Medications
Under a tenth of individuals that would benefit from obesity jabs such as Wegovy are able to get them, caution the World Health Organization as it releases its first advice on the medications.
Considering in excess of 1,000,000,000 individuals worldwide now living with obesity, it is urging more widespread and fairer availability to this class of drugs.
Based on estimates, in excess of 2,000,000,000 could be living with obesity by 2030 without intervention.
"The latest guidance recognises that excess weight is a long-term condition that can be addressed with comprehensive and ongoing care," remarked the agency's head Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and logistical bottlenecks are major barriers to universal access to the treatments that can assist patients in reducing substantial weight, says the body.
GLP-1 Therapy Shortage
Even under the present most optimistic outlook, the manufacturing of GLP-1 therapies would only suffice for approximately 100 million people – under 10% of eligible patients, per the health organization.
The guideline urges nations and manufacturers to increase availability, by measures including voluntary licensing.
The intellectual property rights on the active ingredient – the primary component of the drug Wegovy – is set to lapse in a number of nations in 2026.
The Way Obesity Drugs Work
These medications mimick a body's own hormone to slow digestion, curb appetite and increase the sense of being full so people reduce food intake.
Patients usually start to lose weight in the initial weeks of beginning the weekly injections.
Evidence points to people may put most of the weight back on after a year of halting the treatment, because their normal appetite come back.
To be overweight or obese increases your likelihood for developing health problems, including type 2 diabetes, heart disease, stroke, and specific malignancies.
Excess weight impacts individuals in countries worldwide and was linked to over three and a half million fatalities worldwide in 2024, as per the health agency.
